论文信息 - Persistence with teriparatide in patients with osteoporosis: the UK experience - 字舞流文

Persistence with teriparatide in patients with osteoporosis: the UK experience

C. Cooper | N. Arden | Chris Cooper | D. Fisher | S. Earl | S. Carruthers | M. Goater | C. Cooper | Nigel K. Arden

[1] J. Cramer,et al. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis* , 2005, Current medical research and opinion.

[2] R. Eastell,et al. The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial. , 2004, The Journal of clinical endocrinology and metabolism.

[3] J. Mccombs,et al. Compliance with drug therapies for the treatment and prevention of osteoporosis. , 2003, Maturitas.

[4] Jacques P. Brown,et al. Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database , 2003, Osteoporosis International.

[5] K. McCoy,et al. Tolerability and compliance with risedronate in clinical practice , 2003, Osteoporosis International.

[6] B. Martin,et al. Persistence with Estrogen Therapy in a Postmenopausal Medicaid Population , 1999, Pharmacotherapy.

[7] H. Taggart,et al. Incidence of gastrointestinal side effects due to alendronate is high in clinical practice , 1997, BMJ.

[8] C. Cooper,et al. The crippling consequences of fractures and their impact on quality of life. , 1997, The American journal of medicine.

[9] A. Cano,et al. Compliance to hormone replacement therapy in menopausal women controlled in a third level academic centre. , 1994, Maturitas.

[10] R. Brian Haynes,et al. Compliance in Health Care , 1979 .